Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
Benefits, risks higher for mesh prolapse repair
You may also be interested in...
Transvaginal Mesh Devices Reassessed: FDA Panel Set For September
Industry, physicians and FDA are all prepping for what is likely to be a major meeting in the lifecycle of transvaginal surgical mesh devices early next month.
Transvaginal Mesh Devices Reassessed: FDA Panel Set For September
Industry, physicians and FDA are all prepping for what is likely to be a major meeting in the lifecycle of transvaginal surgical mesh devices early next month.